thiazoles has been researched along with cefiderocol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, A; Matsumoto, S; Nakamura, R; Nishikawa, T; Sato, T; Tsuji, M; Yamano, Y; Yoshizawa, H | 1 |
| Auguste, PS; Bumann, D; Köhler, T; Luscher, A; Mazza, L; Moynié, L; Naismith, JH; Pletzer, D | 1 |
2 other study(ies) available for thiazoles and cefiderocol
| Article | Year |
|---|---|
Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biological Transport; Carbon Radioisotopes; Cefiderocol; Ceftazidime; Cephalosporins; Fluoresceins; Fluorescent Dyes; Iron; Iron Chelating Agents; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Structure-Activity Relationship; Thiazoles | 2016 |
TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Biological Transport; Carrier Proteins; Cefiderocol; Cell Membrane Permeability; Cephalosporins; Membrane Proteins; Monobactams; Pseudomonas aeruginosa; Siderophores; Thiazoles | 2018 |